BioLineRx (BLRX) Short Interest Ratio & Short Volume → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free BLRX Stock Alerts $0.61 -0.02 (-3.16%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BioLineRx Short Interest DataCurrent Short Volume591,500 sharesPrevious Short Volume324,700 sharesChange Vs. Previous Month+82.17%Dollar Volume Sold Short$662,480.00Short Interest Ratio / Days to Cover1.6Last Record DateMarch 31, 2024Outstanding Shares79,940,000 sharesPercentage of Shares Shorted0.74%Today's Trading Volume758,836 sharesAverage Trading Volume397,215 sharesToday's Volume Vs. Average191% Short Selling BioLineRx ? Sign up to receive the latest short interest report for BioLineRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBLRX Short Interest Over TimeBLRX Days to Cover Over TimeBLRX Percentage of Float Shorted Over Time Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. BioLineRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024591,500 shares $662,480.00 +82.2%N/A1.6 $1.12 3/15/2024324,700 shares $373,405.00 +76.6%N/A1 $1.15 2/29/2024183,900 shares $244,587.00 -8.1%N/A0.6 $1.33 2/15/2024200,000 shares $221,000.00 -19.7%N/A0.7 $1.11 1/31/2024249,100 shares $296,429.00 -4.7%N/A0.8 $1.19 1/15/2024261,500 shares $368,715.00 +16.1%N/A0.8 $1.41 Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023225,200 shares $353,564.00 +96.2%N/A0.6 $1.57 12/15/2023114,800 shares $182,532.00 -59.2%N/A0.3 $1.59 11/30/2023281,100 shares $407,595.00 -21.3%N/A0.3 $1.45 11/15/2023357,300 shares $603,837.00 -27.2%N/A0.3 $1.69 10/31/2023490,600 shares $735,900.00 -52.4%N/A0.4 $1.50 10/15/20231,030,000 shares $1.65 million -59.8%N/A0.9 $1.60 9/30/20232,560,000 shares $4.66 million -42.7%N/A2.2 $1.82 9/15/20234,470,000 shares $8.72 million +86.3%N/A4.1 $1.95 8/31/20232,400,000 shares $4.20 million +2.6%N/A2.6 $1.75 8/15/20232,340,000 shares $3.49 million +9.9%N/A6.2 $1.49 7/31/20232,130,000 shares $3.28 million -14.8%N/A4.9 $1.54 7/15/20232,500,000 shares $4.18 million +8.2%N/A5.6 $1.67 6/30/20232,310,000 shares $3.68 million +0.9%N/A4.9 $1.60 6/15/20232,290,000 shares $4.05 million +19.3%N/A4.6 $1.77 5/31/20231,920,000 shares $3.02 million -1.5%N/A3.8 $1.58 5/15/20231,950,000 shares $2.69 million +69.6%N/A4 $1.38 4/30/20231,150,000 shares $1.23 million +21.3%N/A3.1 $1.07 4/15/2023948,300 shares $1.04 million +70.6%N/A2.8 $1.10 3/31/2023556,000 shares $492,894.00 +546.5%N/A1.8 $0.89 3/15/202386,000 shares $52,374.00 +9.7%N/A0.3 $0.61 2/28/202378,400 shares $46,648.00 -64.7%N/A0.3 $0.60 2/15/2023222,100 shares $137,702.00 +97.3%N/A0.9 $0.62 1/31/2023112,600 shares $70,926.74 -42.1%N/A0.3 $0.63 1/15/2023194,600 shares $134,488.06 +9.8%N/A0.6 $0.69 12/30/2022177,200 shares $104,548.00 +22.6%N/A0.5 $0.59 12/15/2022144,500 shares $92,248.80 -11.1%N/A0.4 $0.64 11/30/2022162,500 shares $114,546.25 -37.6%N/A0.4 $0.70 11/15/2022260,200 shares $176,936.00 +7.3%N/A0.7 $0.68 10/31/2022242,500 shares $205,446.00 +33.4%N/A0.9 $0.85 10/15/2022181,800 shares $152,712.00 +127.8%N/A0.7 $0.84 9/30/202279,800 shares $73,815.00 -80.5%N/A0.3 $0.93 9/15/2022408,300 shares $649,197.00 +17.3%N/A1.9 $1.59 8/31/2022348,200 shares $529,264.00 -20.7%N/A2.7 $1.52 8/15/2022439,000 shares $838,490.00 +14.3%N/A3.5 $1.91$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. BLRX Short Interest - Frequently Asked Questions What is BioLineRx's current short interest? Short interest is the volume of BioLineRx shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 591,500 shares of BLRX short. Learn More on BioLineRx's current short interest. What is a good short interest ratio for BioLineRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLRX shares currently have a short interest ratio of 2.0. Learn More on BioLineRx's short interest ratio. Which institutional investors are shorting BioLineRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLineRx: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioLineRx's short interest increasing or decreasing? BioLineRx saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 591,500 shares, an increase of 82.2% from the previous total of 324,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioLineRx's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BioLineRx: Checkpoint Therapeutics, Inc. (12.22%), CalciMedica, Inc. (0.79%), Eledon Pharmaceuticals, Inc. (0.43%), Immuneering Co. (13.97%), Homology Medicines, Inc. (0.81%), Gain Therapeutics, Inc. (1.02%), Jaguar Health, Inc. (7.14%), Reneo Pharmaceuticals, Inc. (13.12%), Aadi Bioscience, Inc. (5.41%), Rockwell Medical, Inc. (2.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short BioLineRx stock? Short selling BLRX is an investing strategy that aims to generate trading profit from BioLineRx as its price is falling. BLRX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioLineRx? A short squeeze for BioLineRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLRX, which in turn drives the price of the stock up even further. How often is BioLineRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLRX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CKPT Short Interest CALC Short Interest ELDN Short Interest IMRX Short Interest FIXX Short Interest GANX Short Interest JAGX Short Interest RPHM Short Interest AADI Short Interest RMTI Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing